The Central Chest Institute of Thailand (CCIT) in Nonthaburi has adopted the Tavi procedure to treat aortic valve stenosis, a ...
Over the past few days, medtech's biggest names gathered in San Francisco for the Transcatheter Cardiovascular Therapies (TCT ...
Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.
New study findings show that utilizing super-high-pressure non-compliant balloons (NCB) is non-inferior to intravascular ...
On Sept. 5, 2025, the U.S. Food and Drug Administration (FDA) approved Inlexzo (gemcitabine intravesical system) for adults ...
BugBiome is an agri-biotech start-up company that is moving to Norwich Research Park from its previous home at the National ...
Pleural Dynamics, Inc. today announced positive results from a prospective, multicenter study evaluating its Automatic ...
A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis ...
National HealthCare Corporation remains a buy despite lease renewal tensions with National Health Investors. Click here to ...
Intermountain Health surgeons have achieved a medical milestone for Utah patients by successfully performing the state’s first minimally invasive ascending ...
News-Medical.Net on MSN
Sirolimus-eluting balloon emerges as a safe and effective option for coronary in-stent restenosis
A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis ...
News-Medical.Net on MSN
Study highlights non-inferiority of super-high-pressure non-compliant balloons in coronary interventions
New study findings show that utilizing super-high-pressure non-compliant balloons (NCB) is non-inferior to intravascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback